The compound patent on the world's best-selling weight-loss drug ended in early 2026 in Canada (Novo let it lapse), China, India and Brazil. Health Canada received generic filings and generics launched in India.
| Where | Status |
|---|---|
| Canada | Free since 2026 |
| China | Free since 2026 |
| India | Free since 2026 |
| Brazil | Free since 2026 |
Limits
The US and Europe stay protected until about 2031 to 2032. Pen-device and formulation patents can still block copies, and every drug needs its own regulatory approval.
Ideas
Market maps, price trackers and supplier lists for generic semaglutide by country.
Sources
Checked 31 October 2026. Report a correction.
More patents
-
Coming 2028Apixaban (Eliquis)Bristol Myers Squibb, Pfizer · 2028 · Patents
One of the world's top-selling drugs. US patents end between 2026 and 2027, but settlements put generic entry around April 2028.
US 2028 -
Coming 2027Ibrutinib (Imbruvica)AbbVie, Johnson & Johnson · 2026 · Patents
The US compound patent runs to December 2026, with pediatric exclusivity to June 2027.
US 2027 -
Coming 2027Palbociclib (Ibrance) and dulaglutide (Trulicity)Pfizer; Eli Lilly · 2027 · Patents
Two blockbuster drugs whose key US protection is listed as ending in 2027.
US 2027 -
New in 2026Lapsed patents (unpaid maintenance fees)Patent owners worldwide · 2006 · Patents
Every patent filed 20 years ago (2006) has now expired, and many younger US patents lapse early because owners stop paying maintenance fees at 3.5, 7.5 and 11.5 years. Their full technical drawings and instructions are free to use.
Worldwide 2026 -
New in 2026Sitagliptin (Januvia, Janumet)Merck · 2026 · Patents
Generics were allowed on the US market from May 2026 under a settlement.
US 2026 -
EarlierLFP (lithium iron phosphate) battery cathodeUniversity of Texas, Hydro-Québec and others · 1996 · Patents
The key LFP cathode patents expired around 2022, letting makers outside China build the cheap, safe batteries now used in many EVs and home storage.
Worldwide 2022
General information, not legal advice. Copyright, patent and trademark status differs by country, edition and translation: check before you publish or sell. Full disclaimer